Squarepoint Ops LLC - GALECTIN THERAPEUTICS INC ownership

GALECTIN THERAPEUTICS INC's ticker is GALT and the CUSIP is 363225202. A total of 63 filers reported holding GALECTIN THERAPEUTICS INC in Q1 2022. The put-call ratio across all filers is 0.57 and the average weighting 0.0%.

Quarter-by-quarter ownership
Squarepoint Ops LLC ownership history of GALECTIN THERAPEUTICS INC
ValueSharesWeighting
Q4 2021$27,000
-82.2%
13,182
-66.4%
0.00%
Q3 2021$152,000
-15.6%
39,191
-30.2%
0.00%
-100.0%
Q2 2021$180,000
+328.6%
56,128
+286.1%
0.00%
Q4 2019$42,000
-17.6%
14,537
+4.6%
0.00%
Q3 2019$51,000
+21.4%
13,901
+37.5%
0.00%
Q2 2019$42,000
-76.3%
10,113
-65.7%
0.00%
-100.0%
Q3 2018$177,000
+68.6%
29,525
+78.1%
0.00%
+100.0%
Q2 2018$105,00016,5780.00%
Other shareholders
GALECTIN THERAPEUTICS INC shareholders Q1 2022
NameSharesValueWeighting ↓
Cutter & CO Brokerage, Inc. 129,488$248,6170.07%
Geneos Wealth Management Inc. 417,350$801,3120.04%
SHEPHERD KAPLAN KROCHUK, LLC 12,000$23,0400.02%
RETIREMENT GUYS FORMULA LLC 11,500$22,0800.02%
Vivaldi Capital Management LP 19,261$36,9810.01%
OSAIC HOLDINGS, INC. 3,275,192$6,288,3450.01%
Traynor Capital Management, Inc. 34,707$66,6380.01%
Atria Wealth Solutions, Inc. 259,800$498,8160.01%
BARRETT & COMPANY, INC. 4,984$9,5690.01%
Wealthspire Advisors, LLC 183,862$353,0160.01%
View complete list of GALECTIN THERAPEUTICS INC shareholders